nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—Bell's palsy—Octreotide—thymus cancer	0.246	0.307	CcSEcCtD
Cyclobenzaprine—HTR2A—phrenic nerve—thymus cancer	0.0892	0.452	CbGeAlD
Cyclobenzaprine—VIIth nerve paralysis—Octreotide—thymus cancer	0.0362	0.045	CcSEcCtD
Cyclobenzaprine—HTR2A—pulmonary artery—thymus cancer	0.0324	0.164	CbGeAlD
Cyclobenzaprine—HTR2A—vein—thymus cancer	0.0295	0.149	CbGeAlD
Cyclobenzaprine—Galactorrhoea—Octreotide—thymus cancer	0.0229	0.0285	CcSEcCtD
Cyclobenzaprine—Paranoia—Octreotide—thymus cancer	0.0218	0.0271	CcSEcCtD
Cyclobenzaprine—Cholestasis—Octreotide—thymus cancer	0.0195	0.0243	CcSEcCtD
Cyclobenzaprine—Numbness—Octreotide—thymus cancer	0.0179	0.0223	CcSEcCtD
Cyclobenzaprine—Acne—Octreotide—thymus cancer	0.0176	0.022	CcSEcCtD
Cyclobenzaprine—Sensory loss—Octreotide—thymus cancer	0.0171	0.0213	CcSEcCtD
Cyclobenzaprine—Muscle twitching—Octreotide—thymus cancer	0.0151	0.0188	CcSEcCtD
Cyclobenzaprine—Gynaecomastia—Octreotide—thymus cancer	0.0133	0.0165	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Octreotide—thymus cancer	0.0108	0.0134	CcSEcCtD
Cyclobenzaprine—Psychotic disorder—Octreotide—thymus cancer	0.0105	0.0131	CcSEcCtD
Cyclobenzaprine—Irritability—Octreotide—thymus cancer	0.0103	0.0128	CcSEcCtD
Cyclobenzaprine—Gastritis—Octreotide—thymus cancer	0.00953	0.0119	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Octreotide—thymus cancer	0.00865	0.0108	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Octreotide—thymus cancer	0.0086	0.0107	CcSEcCtD
Cyclobenzaprine—Weight increased—Octreotide—thymus cancer	0.00847	0.0105	CcSEcCtD
Cyclobenzaprine—Drowsiness—Octreotide—thymus cancer	0.0083	0.0103	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Octreotide—thymus cancer	0.00813	0.0101	CcSEcCtD
Cyclobenzaprine—Jaundice—Octreotide—thymus cancer	0.00809	0.0101	CcSEcCtD
Cyclobenzaprine—Hepatitis—Octreotide—thymus cancer	0.00745	0.00928	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Octreotide—thymus cancer	0.00741	0.00923	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Octreotide—thymus cancer	0.00739	0.00921	CcSEcCtD
Cyclobenzaprine—Tinnitus—Octreotide—thymus cancer	0.00695	0.00865	CcSEcCtD
Cyclobenzaprine—HTR2A—neck—thymus cancer	0.00669	0.0339	CbGeAlD
Cyclobenzaprine—Arrhythmia—Octreotide—thymus cancer	0.00666	0.00829	CcSEcCtD
Cyclobenzaprine—Alopecia—Octreotide—thymus cancer	0.00658	0.0082	CcSEcCtD
Cyclobenzaprine—Flatulence—Octreotide—thymus cancer	0.00639	0.00796	CcSEcCtD
Cyclobenzaprine—CYP1A2—hematopoietic system—thymus cancer	0.00637	0.0323	CbGeAlD
Cyclobenzaprine—Tension—Octreotide—thymus cancer	0.00636	0.00793	CcSEcCtD
Cyclobenzaprine—Nervousness—Octreotide—thymus cancer	0.0063	0.00784	CcSEcCtD
Cyclobenzaprine—Vision blurred—Octreotide—thymus cancer	0.00611	0.00761	CcSEcCtD
Cyclobenzaprine—Tremor—Octreotide—thymus cancer	0.00608	0.00757	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Octreotide—thymus cancer	0.00602	0.00749	CcSEcCtD
Cyclobenzaprine—Agitation—Octreotide—thymus cancer	0.00596	0.00742	CcSEcCtD
Cyclobenzaprine—Malaise—Octreotide—thymus cancer	0.00585	0.00728	CcSEcCtD
Cyclobenzaprine—Vertigo—Octreotide—thymus cancer	0.00583	0.00726	CcSEcCtD
Cyclobenzaprine—Syncope—Octreotide—thymus cancer	0.00582	0.00724	CcSEcCtD
Cyclobenzaprine—Palpitations—Octreotide—thymus cancer	0.00573	0.00714	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Octreotide—thymus cancer	0.0057	0.0071	CcSEcCtD
Cyclobenzaprine—Convulsion—Octreotide—thymus cancer	0.00562	0.007	CcSEcCtD
Cyclobenzaprine—Hypertension—Octreotide—thymus cancer	0.0056	0.00697	CcSEcCtD
Cyclobenzaprine—Chest pain—Octreotide—thymus cancer	0.00552	0.00688	CcSEcCtD
Cyclobenzaprine—Myalgia—Octreotide—thymus cancer	0.00552	0.00688	CcSEcCtD
Cyclobenzaprine—Anxiety—Octreotide—thymus cancer	0.0055	0.00685	CcSEcCtD
Cyclobenzaprine—Discomfort—Octreotide—thymus cancer	0.00545	0.00679	CcSEcCtD
Cyclobenzaprine—Dry mouth—Octreotide—thymus cancer	0.0054	0.00672	CcSEcCtD
Cyclobenzaprine—Oedema—Octreotide—thymus cancer	0.00529	0.00659	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Octreotide—thymus cancer	0.00529	0.00659	CcSEcCtD
Cyclobenzaprine—Shock—Octreotide—thymus cancer	0.00521	0.00649	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Octreotide—thymus cancer	0.00518	0.00645	CcSEcCtD
Cyclobenzaprine—Tachycardia—Octreotide—thymus cancer	0.00517	0.00643	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Octreotide—thymus cancer	0.00512	0.00637	CcSEcCtD
Cyclobenzaprine—Anorexia—Octreotide—thymus cancer	0.00505	0.00628	CcSEcCtD
Cyclobenzaprine—HTR2A—hematopoietic system—thymus cancer	0.00498	0.0253	CbGeAlD
Cyclobenzaprine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00482	0.00601	CcSEcCtD
Cyclobenzaprine—Insomnia—Octreotide—thymus cancer	0.00479	0.00596	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Octreotide—thymus cancer	0.00475	0.00592	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Octreotide—thymus cancer	0.00472	0.00588	CcSEcCtD
Cyclobenzaprine—Somnolence—Octreotide—thymus cancer	0.00471	0.00586	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Octreotide—thymus cancer	0.00466	0.0058	CcSEcCtD
Cyclobenzaprine—CYP3A4—hematopoietic system—thymus cancer	0.00461	0.0234	CbGeAlD
Cyclobenzaprine—Decreased appetite—Octreotide—thymus cancer	0.0046	0.00573	CcSEcCtD
Cyclobenzaprine—Fatigue—Octreotide—thymus cancer	0.00456	0.00568	CcSEcCtD
Cyclobenzaprine—HTR2A—epithelium—thymus cancer	0.00455	0.0231	CbGeAlD
Cyclobenzaprine—CYP2D6—hematopoietic system—thymus cancer	0.00453	0.023	CbGeAlD
Cyclobenzaprine—Constipation—Octreotide—thymus cancer	0.00453	0.00564	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Octreotide—thymus cancer	0.00436	0.00543	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Octreotide—thymus cancer	0.00433	0.00539	CcSEcCtD
Cyclobenzaprine—Urticaria—Octreotide—thymus cancer	0.0042	0.00524	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Octreotide—thymus cancer	0.00418	0.00521	CcSEcCtD
Cyclobenzaprine—CYP1A2—thyroid gland—thymus cancer	0.00407	0.0207	CbGeAlD
Cyclobenzaprine—Hypersensitivity—Octreotide—thymus cancer	0.0039	0.00486	CcSEcCtD
Cyclobenzaprine—Asthenia—Octreotide—thymus cancer	0.0038	0.00473	CcSEcCtD
Cyclobenzaprine—Pruritus—Octreotide—thymus cancer	0.00374	0.00466	CcSEcCtD
Cyclobenzaprine—CYP1A2—lung—thymus cancer	0.0037	0.0188	CbGeAlD
Cyclobenzaprine—HTR2A—pituitary gland—thymus cancer	0.00369	0.0187	CbGeAlD
Cyclobenzaprine—Diarrhoea—Octreotide—thymus cancer	0.00362	0.00451	CcSEcCtD
Cyclobenzaprine—Dizziness—Octreotide—thymus cancer	0.0035	0.00436	CcSEcCtD
Cyclobenzaprine—Vomiting—Octreotide—thymus cancer	0.00337	0.00419	CcSEcCtD
Cyclobenzaprine—Rash—Octreotide—thymus cancer	0.00334	0.00416	CcSEcCtD
Cyclobenzaprine—Dermatitis—Octreotide—thymus cancer	0.00333	0.00415	CcSEcCtD
Cyclobenzaprine—Headache—Octreotide—thymus cancer	0.00332	0.00413	CcSEcCtD
Cyclobenzaprine—Nausea—Octreotide—thymus cancer	0.00314	0.00392	CcSEcCtD
Cyclobenzaprine—HTR2A—lung—thymus cancer	0.00289	0.0147	CbGeAlD
